Next Article in Journal
Cancer Stem Cell Markers—Clinical Relevance and Prognostic Value in High-Grade Serous Ovarian Cancer (HGSOC) Based on The Cancer Genome Atlas Analysis
Previous Article in Journal
A High-Quality Genome Sequence of the Penicillium oxalicum 5-18 Strain Isolated from a Poplar Plantation Provides Insights into Its Lignocellulose Degradation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

PAX2 Gene Mutation in Pediatric Renal Disorders—A Narrative Review

1
Department of Pediatrics I, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania
2
Laboratory of Genetics, Department of Genetics, Emergency County Hospital, 540142 Targu Mures, Romania
3
Center for Advanced Medical and Pharmaceutical Research, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540142 Targu Mures, Romania
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2023, 24(16), 12737; https://doi.org/10.3390/ijms241612737
Submission received: 9 July 2023 / Revised: 3 August 2023 / Accepted: 10 August 2023 / Published: 13 August 2023
(This article belongs to the Section Molecular Genetics and Genomics)

Abstract

The PAX2 gene is a transcription factor that is essential for the development of the urinary system among other transcription factors. The role of PAX2 is highlighted from the seventh week of gestation, when it is involved in development processes and the emergence of nephrons and collecting tubes. Being an important factor in renal development, mutations of this gene can produce severe alterations in the development of the urinary tract, namely congenital anomalies of the kidneys and urinary tract. The first reported cases described with the PAX2 mutation included both renal anomalies and the involvement of other organs, such as the eyes, producing renal coloboma syndrome. Over the years, numerous cases have been reported, including those with only renal and urinary tract anomalies. The aim of this review is to present a summary of pediatric patients described to have mutations in the PAX2 gene to contribute to a better understanding of the genetic mechanism causing anomalies of the kidneys and urinary tract. In this review, we have included only pediatric cases with renal and urinary tract disorders, without the involvement of other organs. From what we know so far from the literature, this is the first review gathering pediatric patients presenting the PAX2 mutation who have been diagnosed exclusively with renal and urinary tract disorders.
Keywords: PAX2 gene; renal disorder; congenital anomalies; kidney; urinary tract; children PAX2 gene; renal disorder; congenital anomalies; kidney; urinary tract; children

Share and Cite

MDPI and ACS Style

Muntean, C.; Chirtes, C.; Baczoni, B.; Banescu, C. PAX2 Gene Mutation in Pediatric Renal Disorders—A Narrative Review. Int. J. Mol. Sci. 2023, 24, 12737. https://doi.org/10.3390/ijms241612737

AMA Style

Muntean C, Chirtes C, Baczoni B, Banescu C. PAX2 Gene Mutation in Pediatric Renal Disorders—A Narrative Review. International Journal of Molecular Sciences. 2023; 24(16):12737. https://doi.org/10.3390/ijms241612737

Chicago/Turabian Style

Muntean, Carmen, Camelia Chirtes, Balazs Baczoni, and Claudia Banescu. 2023. "PAX2 Gene Mutation in Pediatric Renal Disorders—A Narrative Review" International Journal of Molecular Sciences 24, no. 16: 12737. https://doi.org/10.3390/ijms241612737

APA Style

Muntean, C., Chirtes, C., Baczoni, B., & Banescu, C. (2023). PAX2 Gene Mutation in Pediatric Renal Disorders—A Narrative Review. International Journal of Molecular Sciences, 24(16), 12737. https://doi.org/10.3390/ijms241612737

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop